Drug Shortage Report for ALREX
| Report ID | 6454 |
| Drug Identification Number | 02320924 |
| Brand name | ALREX |
| Common or Proper name | ALREX |
| Company Name | BAUSCH & LOMB INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LOTEPREDNOL ETABONATE |
| Strength(s) | 0.2% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Packaging size | - |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-05-31 |
| Actual start date | |
| Estimated end date | 2017-06-07 |
| Actual end date | 2017-07-14 |
| Shortage status | Resolved |
| Updated date | 2017-07-15 |
| Company comments | Delay in Manufacturing |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2017-07-15 | English | Compare |
| v7 | 2017-07-14 | French | Compare |
| v6 | 2017-07-14 | English | Compare |
| v5 | 2017-06-02 | French | Compare |
| v4 | 2017-06-02 | English | Compare |
| v3 | 2017-05-06 | English | Compare |
| v2 | 2017-04-11 | French | Compare |
| v1 | 2017-04-11 | English | Compare |
Showing 1 to 8 of 8